Sequana Medical 2023 Investor Presentation

Sequana Medical investor presentation detailing its portfolio of fluid overload treatment solutions for liver disease, heart failure, and cancer. The presentation covers the alfapump® system, which is under clinical investigation via the POSEIDON Study, and DSR® therapy in pre-clinical and clinical development.